CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −3 | $957.75 | $3K | 18,419 |
| 2024-02-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −5 | $958.65 | $5K | 18,414 |
| 2024-02-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −8 | $959.68 | $8K | 18,406 |
| 2024-02-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −10 | $960.52 | $10K | 18,396 |
| 2024-02-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −4 | $961.37 | $4K | 18,392 |
| 2024-02-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −6 | $962.49 | $6K | 18,386 |
| 2024-02-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −4 | $963.73 | $4K | 18,382 |
| 2024-02-01 | McCourt Marion EVP Commercial | Sale 10b5-1 | −273 | $945.61 | $258K | 14,789 |
| 2024-01-31 | Landry Robert E EVP Finance CFO | Option exercise | +400 | $378.98 | $152K | 23,856 |
| 2024-01-31 | Landry Robert E EVP Finance CFO | Shares withheld for taxes | −282 | $953.42 | $269K | 23,574 |
| 2024-01-31 | Landry Robert E EVP Finance CFO | Option exercise · Non-Qualified Stock Option (right to buy) | −400 | 12,187 | ||
| 2024-01-30 | Bassler Bonnie L Director | Option exercise 10b5-1 | +827 | $380.95 | $315K | 2,209 |
| 2024-01-30 | Bassler Bonnie L Director | Sale 10b5-1 | −827 | $959.00 | $793K | 1,382 |
| 2024-01-30 | Bassler Bonnie L Director | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −827 | 827 | ||
| 2024-01-24 | Landry Robert E EVP Finance CFO | Option exercise | +500 | $378.98 | $189K | 23,808 |
| 2024-01-24 | Landry Robert E EVP Finance CFO | Shares withheld for taxes | −352 | $951.26 | $335K | 23,456 |
| 2024-01-24 | Landry Robert E EVP Finance CFO | Option exercise · Non-Qualified Stock Option (right to buy) | −500 | 12,587 | ||
| 2024-01-23 | GOLDSTEIN JOSEPH L Director | Option exercise 10b5-1 | +2,707 | $625.60 | $1.7M | 9,089 |
| 2024-01-23 | GOLDSTEIN JOSEPH L Director | Sale 10b5-1 | −2,707 | $950.00 | $2.6M | 6,382 |
| 2024-01-23 | GOLDSTEIN JOSEPH L Director | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −2,707 | 0 |
Page 38 of 49 · 971 trades